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Abstract
Nucleic acid sensor elements are proving increasingly useful in biotechnology and biomedical applications. A number of
ligand-sensing, conformational-switching ribozymes (also known as allosteric ribozymes or aptazymes) have been
generated by some combination of directed evolution or rational design. Such sensor elements typically fuse a molecular
recognition domain (aptamer) with a catalytic signal generator (ribozyme). Although the rational design of aptazymes has
begun to be explored, the relationships between the thermodynamics of aptazyme conformational changes and aptazyme
performance in vitro and in vivo have not been examined in a quantitative framework. We have therefore developed a
quantitative and predictive model for aptazymes as biosensors in vitro and as riboswitches in vivo. In the process, we have
identified key relationships (or dimensionless parameters) that dictate aptazyme performance, and in consequence,
established equations for precisely engineering aptazyme function. In particular, our analysis quantifies the intrinsic trade-
off between ligand sensitivity and the dynamic range of activity. We were also able to determine how in vivo parameters,
such as mRNA degradation rates, impact the design and function of aptazymes when used as riboswitches. Using this
theoretical framework we were able to achieve quantitative agreement between our models and published data. In
consequence, we are able to suggest experimental guidelines for quantitatively predicting the performance of aptazyme-
based riboswitches. By identifying factors that limit the performance of previously published systems we were able to
generate immediately testable hypotheses for their improvement. The robust theoretical framework and identified
optimization parameters should now enable the precision design of aptazymes for biotechnological and clinical
applications.
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Introduction
Nucleic acid binding species (aptamers) have emerged as a
powerful tool for molecular recognition, and have begun to be
widely adapted as biosensors, in drug-delivery systems, and as
regulatory elements that control gene expression [1–4]. Naturally
occurring nucleic acid regulatory elements, riboswitches, have
been discovered in a variety of organisms and control the
expression of a wide range of genes [5].
One of the major advantages of aptamers over their protein
counterparts is that they can be easily coupled to other functional
RNAs based largely on secondary structural considerations in
order to generate allosteric constructs. To a large extent aptamer-
based biosensors (both in vitro and in vivo) can be classified into two
major categories: (i) those in which the aptamer binding influences
the hybridization state of other nucleic acids (for in vitro examples
see [6,7]; for in vivo examples, see [8]), and (ii) those in which
aptamer binding influences the catalysis of a ribozyme (for in vitro
examples, see [9–11]; for in vivo examples, see [12–15]. These
allosteric ribozymes derived from aptamers are also known as
aptazymes.
While there are numerous empirical examples of aptazymes
operating as biosensors and regulatory elements, quantitative
analyses of aptazyme performance and the development of design
principles for aptazymes have seldom been attempted and are
largely incomplete [10,16]. Recently, Beisel and Smolke developed
a similar model for riboswitch function [16]. However, only
qualitative trends were reported. For example, while it was
concluded that ‘‘a design that is biased toward forming the
disrupted-aptamer conformation will generally increase the
dynamic range …(but) require higher ligand concentrations to
modulate protein level,’’ the more useful quantitative relationship
between dynamic range of activity and ligand sensitivity that
should enable rational design was not described. Similarly, the
impact of fundamental kinetic parameters such as the ribozyme
cleavage rate constant and mRNA degradation rate constant on
the behavior of riboswitches was not analyzed. Additionally, those
numerical solutions that were given were based on arbitrary
parameters. For all of these reasons it is unclear what parameters
need to be measured for the quantitative prediction of riboswitch
function. It is also unclear how and to what extent the parameters
can be optimized for improved function.
To establish a better quantitative understanding of aptazyme-
based biosensors and riboswitches, we analyze a two-state model
for aptazyme function and illustrate: (i) the quantitative relation-
ship between the dynamic range of activity and ligand sensitivity;
(ii) the variables that limit aptazyme function; (iii) the minimal set
of readily measurable parameters that are necessary and sufficient
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design optimal aptazyme-based biosensors for both in vitro and in
vivo applications. In addition, we apply this model to published
data for a previously engineered riboswitch system [14] and show
that this system is severely limited both by slow ribozyme cleavage
relative to mRNA degradation and likely by the intracellular
concentration of theophylline.
Results/Discussion
Schemes for the design of aptazymes
The ability to predict the secondary structure of functional
RNA molecules has made it possible to rationally design allosteric
ribozymes. Aptamer secondary structures are superimposed upon
or swapped with portions of ribozyme secondary structures
(Figure 1A), and interactions between the two domains are often
controlled by junction sequences (so-called communication
modules). One commonly used strategy to design ligand-activated
aptazymes can be described as ‘binding assisted stem-formation’
(Figure 1B) in which a weak but functionally important stem that
is shared by the aptamer and the ribozyme is stabilized by ligand-
binding [12,13]. Other design strategies include ‘slip structures’
(Figure 1C; [9]) and ‘strand replacement’ (Figure 1D; [14,15]).
In these latter strategies the ligand-induced stabilization of the
aptamer helix causes a conformational change in the secondary
structure of the ribozyme that either promotes or inhibits
catalysis. Taken together, all of these strategies assume a two-
state model for the aptazyme in which one of the states is
stabilized by ligand-binding.
To garner better insights into how to design aptazymes,
we will attempt to model the interrelationships between
aptazyme conformational change, ligand-binding, and cataly-
sis. In this way we can separate intrinsic variables (including the
aptamer:ligand affinity and the ribozyme catalytic rate con-
stant) from extrinsic or ‘engineerable’ variables (including the
equilibrium constant between the two conformers). While the
catalytic rates of the less active conformer and the more active
conformer are also extrinsic variables, they should almost
always be minimized (to zero if possible) and maximized (to the
rate of the ribozyme sans aptamer if possible), respectively. For
simplicity, we develop our analyses with self-cleaving apta-
zymes, but the model should be generalizable to aptazymes with
other catalytic activities.
A model for ligand-activated and ligand-inhibited
aptazymes as in vitro biosensors
The general model for ligand-modulated ribozymes is similar to
that for allosteric protein enzymes (Figure 2A). In this model, the
aptazyme can assume two interchangeable conformations A and B
with internal equilibrium constant Kint (see Text S3 for a
summary of terms), each of which has particular (but different)
ligand-binding affinities defined by association constants Ka(A) and
Ka(B), respectively, and particular (but different) cleavage activities
defined by cleavage rate constants kCle(A) and kCle(B), respectively.
Since in most cases it is the local structure of the catalytic core (as
opposed to the ligand-binding site) that determines the catalytic
activity of the aptazyme, it is assumed that the aptazyme-ligand
complexes AL and BL have the same cleavage rate constants as the
unbound aptazymes A and B, respectively. Furthermore, we only
consider the situation where all four species (A, B, AL and BL) are
in equilibrium at the start of the reaction. When the conformer
that possesses higher ligand-binding affinity also has higher
catalytic activity the aptazyme is called ligand-activated; when
the conformer that possesses higher binding affinity has lower
catalytic activity the aptazyme is called ligand-inhibited. In general
we assign conformation B to have the higher ligand-binding
affinity (Ka(B).Ka(A)). Thus, ligand can be thought to thermody-
namically shift the A conformer towards B. Since most two-state
models for allosterism assume that the ligand primarily influences
the population of catalytically inactive and active conformations,
we assume that the less catalytically active conformer has zero
activity and the more catalytically active conformer has the same
cleavage rate constant as the ribozyme sans aptamer (denoted as
kCle). Formally,
kCle(A)~0 and kCle(B)~kCle for ligand-activated aptazymes
Figure 1. Schemas for aptazyme design. (A) The general strategy
for designing aptazymes, where the aptamer and the ribozyme are
shown in blue and red, respectively. The stem used to connect the
aptamer and the ribozyme (the communication module) is highlighted
in a dotted green box. (B) Schema for ‘binding-assisted stem-formation.’
(C) Schema for a ‘slip structure.’ (D) Schema for ‘strand replacement’. In
(B) to (D), the aptamer domain, the ribozyme domain and the
communication module are shown in blue, red and green, respectively.
The ligand for the aptamer domain is shown as a blue hexagon. Long
gray lines indicate base-pairing; short grays lines (on the left) indicate
un-paired bases; and dashed gray lines (on the right) indicate mis-
paired bases or non-canonical base-pairs.
doi:10.1371/journal.pcbi.1000620.g001
Author Summary
Aptamers are nucleic acids that bind their cognate ligands
(ranging from metal ions to small molecules to proteins)
specifically and tightly. Through rational design and/or
directed evolution, aptamers can be engineered into
allosteric nucleic acids whose conformations can be
regulated by their ligands. Aptamer beacons, aptazymes,
and riboswitches all undergo ligand-dependent conforma-
tional changes, and have been adapted to signal the
concentration of their ligands. However, there is currently
no model that can be used to predict how the energetics
of conformational change affects signaling, either in vitro
or in vivo. We have developed a model that identifies what
parameters can be optimized to best yield signals. By
focusing on these parameters, it should be possible to
more readily design or select more effective conformation-
switching nucleic acid biosensors.
Design Principles for Allosteric Ribozymes
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kCle(A)~kCle and kCle(B)~0 for ligand-inhibited aptazymes:
Another simplifying assumption is that the complex BL is much
more thermodynamically stable than AL, and thus we can ignore
the existence of AL and reduce the model to the path outlined in
green in Figure 2A. This reduced model assumes that the A
conformer must spontaneously refold into the B conformer in
order to bind the ligand and thus excludes ligand-induced
refolding of the aptazyme. This reduction is valid when two
conditions are met: (i) the energy barrier between A and B is not
much higher than that between AL and BL, so that aptazyme
refolding does not rely on the ligand as a catalyst; and (ii) when the
aptazyme is bound to the ligand the aptazyme almost exclusively
assumes the BL conformation. We will use this reduced model in
the following analyses.
The in vitro performance of a self-cleaving aptazyme is usually
evaluated by plotting the first-order apparent cleavage rate
constant (kapp; the initial cleavage rate divided by the total
concentration of aptazyme) against the total ligand concentration
([Ltot]). As a starting point of our model, we show how kapp, which
is in fact contributed to by all three aptazyme conformations, is
determined by the variables shown in Figure 2A.
Assuming that ligand-binding is much faster than aptazyme
cleavage ([L]kon(B) + koff(B)&kCle(B)) the initial cleavage rate constant
should directly reflect the initial fraction of each of the three
Figure 2. Kinetic model and performance of aptazymes as in vitro biosensors. (A) Two-state model for aptazyme function. The aptazyme
conformers with low and high affinities for ligand are shown as A and B, respectively. The ligand-bound states of these two conformers are shown as
AL and BL. Kint is the equilibrium constant for the A-to-B transition. Ka(A) and Ka(B) are the association constants for the ligand (L, shown as a blue
hexgon) with the A conformer and the B conformer, respectively. The first-order cleavage rate constants for conformer A and conformer B are defined
as kCle(A) and kCle(B), respectively. Under certain conditions (see text), the AL conformer can be ignored and the model can be reduced to the enclosed
green box. (B) The effect of cleavage tendency (v) on the performance of ligand-activated aptazymes. (D) The effect of cleavage tendency (v) on the
performance of ligand-inhibited aptazymes. In (B) and (D) the relative ligand concentration ([Ltot]/Kd) is shown on the horizontal axis and the relative
apparent cleavage rate constant (kapp/kCle) is shown on the vertical axis. The basal cleavage rate constants in the absence of ligand are shown by
horizontal dashed lines. The values of EC
 
50 are shown as a vertical dotted lines. (C) The relationship between the cleavage tendency (v)o fa n
aptazyme and the realistic ligand-dependent change in activity (gR, Realistic) is shown for ligand-activated aptazymes (left) and ligand-inhibited
aptazymes (right). This relationship is shown for different maximum available ligand concentrations (L
 
max).
doi:10.1371/journal.pcbi.1000620.g002
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kapp~
½A 
½A z½B z½BL 
kCle(A)z
½B z½BL 
½A z½B z½BL 
kCle(B): ð1Þ
If ligand-binding is slow relative to cleavage, the apparent rate
constant would reflect the rate of binding (the rate limiting step)
instead of cleavage. Based on the assigned definitions for
parameters (see Text S1 for derivation) the fraction of A can be
calculated to be:
fA~
½A 
½A z½B z½BL 
~
1
1zKint 1zL
  ðÞ
ð2Þ
and the total fractions of B and BL are:
fBzBL~
½B z½BL 
½A z½B z½BL 
~
Kint 1zL
  
1zKint 1zL
  ðÞ
: ð3Þ
where L
 
is relative ligand concentration, defined as the ligand
concentration divided by the dissociation constant (Kd or
1
Ka(B)
)o f
the aptamer domain. The introduction of relative ligand
concentration means that Kd is only a scaling factor for ligand
concentration. In other words, two aptazymes with the same Kint
but different Kd values would be indistinguishable in terms of their
performance with respect to relative ligand concentrations.
In the absence of ligand, fB+BL and fA equal to
Kint
1zKint
and
1
1zKint
, respectively. Thus the ratios
Kint
1zKint
and
1
1zKint
are the
fraction of cleavage-competent conformers in the absence of
ligand for ligand-activated aptazymes and ligand-inhibited apta-
zymes, respectively. We term these ratios ‘cleavage tendency’ and
denote them as v. Formally:
v~
Kint
1zKint
for ligand-activated aptazymes and
v~
1
1zKint
for ligand-inhibited aptazymes:
It should be noted that the relationship between v and Kint is
dependent on the type of the aptazyme (ligand-activated or ligand-
inhibited). When the aptazyme type is specified, v can be used
interchangeably with Kint. Since in many cases the equations are in
simpler form when v is used instead of Kint, we will primarily use
v in the following derivations and analyses. From equations (1,3)
and earlier assumptions, the relationship between kapp and the
relative ligand concentration L
 
are:
kapp~
Kint 1zL
  
1zKint 1zL
  ðÞ
kCle
or
kapp~
v 1zL
  
1{v ðÞ zv 1zL
  ðÞ
kCle ð4Þ
for ligand-activated aptazymes, and:
kapp~
1
1zKint 1zL
  ðÞ
kCle
or
kapp~
v
vz 1{v ðÞ 1zL
  ðÞ
kCle ð5Þ
for ligand-inhibited aptazymes.
Design principles for ligand-activated aptazymes as in
vitro biosensors
The kapp-vs-L
 
curve is an increasing hyperbola for ligand-
activated aptazymes. The relationship between the parameters
that describe the hyperbola (highest value, lowest value, and half-
value concentration) and the model parameters (v and kCle) can be
determined by rewriting equation (4) as:
kapp~
L
 
L
 zEC
 
50
kapp(max){kapp(min)

zkapp(min)
where kapp(min) and kapp(max) are the minimal and maximum
apparent cleavage rate constants. These rate constants are reached
in the absence of ligand and at a saturating concentration of
ligand, respectively. EC
 
50 is the relative ligand concentration at
which the kapp is half-way between kapp(min) and kapp(max).A sa
result:
kapp(min)~vkCle ð6Þ
kapp(max)~kCle ð7Þ
EC
 
50~
1
v
ð8Þ
According to the definition of relative concentration, EC
 
50 is
dimensionless and scales relative to the Kd of the aptamer domain,
the absolute EC50 (with unit of a concentration) can be calculated
with the equation:
EC50~EC
 
50:Kd:
It is noteworthy that EC50 is often regarded as the ‘apparent Kd of
the aptazyme’ and can be confused with Kd. In fact, the Kd is an
intrinsic variable reflecting the affinity between the aptamer and the
ligand, while EC50 is design-dependent. From equation (8) it can
be seen that EC50 is always greater than Kd and is inversely
correlated with v, since the ligand binding-competent conforma-
tion B is only a fraction of the total aptazyme population and a
smaller v means this conformation is proportionately disfavored.
In addition to EC50, another important parameter for
describing the performance of a ligand-activated aptazyme is the
fold-activation of the cleavage rate constant when ligand
concentration increases from 0 to infinite. We denote this fold-
activation as gR, Theoretical which is defined as:
gR, Theoretical~
kapp(max)
kapp(min)
Comparing equations (6) and (7) it is obvious that for ligand-
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gR, Theoretical~
1
v
, ð9Þ
which means that the maximum fold-activation is solely
determined by the cleavage tendency of the aptazymes. In order
to engineer aptazyme that have a higher gR, Theoretical, one must
minimize v, i.e. the cleavage-competent conformation should be
disfavored in the absence of ligand. For example to achieve a
.10
2-fold activation in the presence of ligan v should also be no
greater than 10
22, which in turn means that the free energy of
conformation A should be disfavored by at least 2.8 kcal/mole (at
37uC) relative to conformation B. However, a low value of v
would also increase the concentration of ligand that was required
to fully activate the aptazyme. This can be seen by comparing
equations (8) and (9), yielding:
EC
 
50~gR, Theoretical
or
EC50~gR, TheoreticalKd ð10Þ
In other words, high sensitivity (low EC50) and a large dynamic
range of kapp (high gR, Theoretical) cannot be obtained simultaneous-
ly (Figure 2B). Conversely, if an aptazyme displays a mediocre
EC50 and also has a large fold-activation it can be inferred that the
aptamer domain may actually have a very high affinity for its
ligand. For example, a lysozyme-dependent L1-ligase previously
selected by Robertson and Ellington [11] exhibits an EC50 of
1.5 mM but has a 3100-fold activation in the presence of saturating
concentration of ligand (which means gR, Theoretical$3100).
According to equation (10), the aptamer domain of this aptazyme
may have a Kd as low as 500 pM.
To reach the full theoretical dynamic range of kapp, the ligand
concentration should vary from 0 to infinite, which is of course
impossible. The upper limit of the realistic dynamic range of kapp for
a ligand-activated aptazyme is determined by the kapp at the
highest possible concentration of ligand. Therefore, when
designing aptazymes it is important to consider the fold-activation
of the cleavage rate constant when ligand concentration increases
from 0 to its highest possible concentration. We denote this fold-
activation as gR, Realistic and formally define it as:
gR, Realistic~
kapp L
 
~L
 
max

kapp(0)
where the L
 
max is the highest possible relative ligand concentra-
tion.
Since decreasing cleavage tendency is a double-edged sword in
that it increases gR, Theoretical but at the same time requires higher
ligand concentration to achieve half activation, it is important to
find the cleavage tendency that gives optimal aptazyme perfor-
mance (the highest gR, Realistic). To find the optimal cleavage
tendency, it is useful to determine the explicit expression of
gR, Realistic as a function of v, which is:
gR, Realistic~
1zL
 
max
1zL
 
maxv
ð11Þ
Interestingly, from this equation it is clear that for any L
 
max.0,
gR, Realistic increases monotonically as the cleavage tendency v
decreases, as shown in (Figure 2C, left panel). In other words, it
is always beneficial to have a lower cleavage tendency when the
goal is to design the aptazyme to maximize gR, Realistic.
Practically, the only negative effect of engineering small
cleavage tendencies in aptazymes is that the absolute value of
kapp L
 
~L
 
max

is small, and thus the rate of cleavage and signal
generated by the aptazyme may be small. Therefore, as a practical
guideline for designing ligand-activated aptazymes as in vitro
biosensors the cleavage tendency should be minimized as long as
the value kapp L
 
~L
 
max

still falls within a range that is readily
detected by a given assay.
Design principles for ligand-inhibited aptazymes as in
vitro biosensors
The kapp-vs-L
 
curve for a ligand-inhibited aptazyme is a
decreasing hyperbola, whose descriptor can be solved by
rearranging equation (5) to the form:
kapp~
EC
 
50
L
 zEC
 
50
kapp(max){kapp(min)

zkapp(min)
yielding:
kapp(min)~0 ð12Þ
kapp(max)~vkCle ð13Þ
EC
 
50~
1
1{v
ð14Þ
Here the definition of the fold-inhibition over the theoretical
dynamic range of kapp (gR, Theoretical) is problematic since the
theoretical lower limit of kapp is 0 and therefore gR, Theoretical for a
ligand-inhibited aptazyme would be infinite. The value gR, Realistic
(now defined as
kapp(0)
kapp L
 ~L
 
max
 ) will be dependent on the design
of the aptazyme (i.e., the choice of the cleavage tendency v) and
on the highest available concentration of ligand (L
 
max). Because
the inhibited aptazyme is hyperbolically controlled by the ligand
(see Figure 2D), the lower realistic limit of kapp will be very hard
to reach, and the range of kapp values for ligand-inhibited
aptazymes will be heavily dependent on the ratio of L
 
max to
EC
 
50. A low EC
 
50 will be crucial if the highest possible
concentration of ligand is limited or if the intrinsic affinity of the
aptamer domain is low.
According to equation (14), a lower EC
 
50 should be engineered
by decreasing v. However, by comparing equations (13) and (14)
we find:
kapp(max)~ 1{
1
EC
 
50

kCle ð15Þ
which in turn implies that lowering EC
 
50 will decrease the upper
bound on possible kapp values (Figure 2D). Once again there is a
compromise between ligand sensitivity and the dynamic range of
activity.
Again, to find the cleavage tendency that yields the highest
gR, Realistic for a given L
 
max, the expression of gR, Realistic as a
Design Principles for Allosteric Ribozymes
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gR, Realistic~1z 1{v ðÞ L
 
max ð16Þ
Interestingly, as cleavage tendency v increases from 0 to 1,
gR, Realistic decreases linearly from 1+L
 
max to 1 (Figure 2C, right
panel). Consequently, when designing ligand-inhibited aptazymes
as in vitro biosensors, it is also always beneficial to choose a low
cleavage tendency as long as kapp(max) is still readily detectable.
In summary, for both ligand-activated and ligand-inhibited
aptazymes there are trade-offs between ligand sensitivity and the
dynamic range of activity, reflected by equations (10) and (15),
respectively. However, when attempting to maximize gR, Realistic it
is always a good strategy to choose a low cleavage tendency, as
shown by equations (11) and (16) and Figure 2C.
Aptazymes as in vivo riboswitches
Aptazymes can be inserted into mRNAs in order to regulate
their stabilities and translation efficiencies, thereby functioning
similar to natural riboswitches in vivo. In such applications,
aptazyme regulation will of necessity be further modulated by
the dynamic processes surrounding RNA metabolism, including
transcription, processing, transportation, translation and degrada-
tion. In addition, the most readily observed signals will be steady
state mRNA or protein concentrations, instead of cleavage rate
constants.
The most straightforward strategy for adapting aptazymes to
gene regulation is to engineer a drug-responsive cleavase (such
as a hammerhead aptazyme) to target a particular mRNA.
However, despite decades of effort, gene regulation based on
trans-cleaving ribozymes has proven largely unsuccessful. Gene
regulation via ligand-responsive ribozyme was paradoxically
first demonstrated in a natural system, where a novel ribozyme
located at the 59 UTR of the glmS gene of B. subtilis was found to
self-cleave primarily in the presence of GlcN6P [17]. This
cleavage has been shown to destabilize glmS mRNA and thus to
down-regulate glmS expression [18]. Interestingly, biochemical
study revealed that glmS ribozyme is not an allosteric ribozyme
per se, since GlcN6P does not allosterically regulate glmS
ribozyme but rather serves as a cofactor which directly
contributes to catalysis [19].
More recently, the engineering of artificial riboswitches based
on cis-cleaving aptazymes has achieved some success. By
connecting the anti-theophylline or anti-tetracycline aptamers to
the tobacco ringspot virus (TRSV) HHRz via rationally designed
or selected communication modules, Win and Smolke engineered
aptazymes that, when inserted to the 39 UTR of the GFP gene,
could regulate GFP expression in yeast in response to theophylline
or tetracycline concentration [14]. The reported dynamic range of
GFP expression level was 20,25-fold (Figure 2 of [14]). However,
closer inspection of the raw data provided in the supplementary
material (Figure S13 of [14]) showed that the dynamic range of
GFP expression level was actually much lower. Among all the
aptazyme constructs that were designed and tested, most displayed
only ,1.5-fold regulation and the best ones displayed ,2.5-fold
regulation. The discrepancy between the interpretation and the
data was due to redefinition of the word ‘fold’ by the authors.
Although the word ‘fold’ is generally used to express the ratio of
two quantities, Win and Smolke used ‘fold’ as a unit of absolute
quantity of GFP expression [14]. For example, the GFP expression
level from an unengineered plasmid was defined as ‘50 fold.’
Therefore, when the GFP expression level from an engineered
plasmid changed from ‘20 fold’ in the absence of theophylline to
‘43 fold’ in the presence of theophylline, a dynamic range of
‘(43220=) 23 fold’ could be claimed. Most researchers would
instead estimate the dynamic range to be (43/20=) 2.2-fold. Win
and Smolke have also reported that multiple aptazymes inserted
into the 39 UTR could act as logic gates for gene expression, but
the raw data necessary to evaluate these claims were not
immediately available [15].
These designs were of necessity eukaryote-specific, since the 39
polyA:59 cap interaction is crucial for efficient protein translation.
A prokaryote-specific system has been developed by Wieland et al.
in which the ribosome-binding site (RBS) of a reporter gene was
embedded in stem I of the Schistosomal HHRz, such that the self-
cleavage of the HHRz liberated the RBS for translation initiation
[12,13]. Through rational design and genetic screening, a
theophylline-responsive aptazyme that exhibited 10-fold regula-
tion of the expression of the reporter gene was generated. The
fold-regulation achieved by these authors (1.2- to 10- fold) are far
smaller than those that have been routinely demonstrated in vitro
(10
2-,10
4- fold ).
To explain this discrepancy, we will explore a simple kinetic
model. In this model, the eukaryotic-specific system, where an
aptazyme is placed within the 39 UTR of a mRNA, will be used.
That said, it should be noted that self-cleaving HHRzs placed
within the 59 UTR can abet even stronger inhibition of gene
expression [20], but such a model would be inherently more
challenging because it would have to take into account the
continuous scanning by the pre-initiation complex.
Modeling inhibition of gene expression by a
constitutively active ribozyme
We first model how gene expression can be inhibited by a
constitutively active, self-cleaving ribozyme (Figures 3A and 3B).
In these models, we assume that the steady-state concentration of a
protein is proportional to the steady state concentration of its
intact mRNA. In contrast, mRNA with a cleaved 39 UTR is
assumed to have a negligible translation efficiency or is rapidly
degraded [21].
In the absence of ribozyme cleavage (Figure 3A) the steady
state concentration of mRNA ([R]ss)i s
vTxn
kDeg
. When a constitutively
active self-cleaving ribozyme is inserted to the 39 UTR of the
mRNA (Figure 3B), the steady state concentration of intact
mRNA should depend on its cleavage rate, as well as on the
transcription and degradation rates, specifically:
½R ss~
vTxn
kDegzkCle
ð17Þ
If we define the relative steady-state intact mRNA concentra-
tion without ribozyme as 1, then the relative steady-state intact
mRNA concentration of an mRNA that harbors a ribozyme is:
½R Rel~
1
1zD
ð18Þ
where D~
kCle
kDeg
is the ratio of cleavage rate constant to the
spontaneous degradation rate constant. The extent to which gene
expression can be inhibited by an inserted ribozyme is directly
determined by this ratio D, which implies that the rate of
spontaneous degradation of mRNA also directly influences how
much inhibition a given ribozyme can potentially achieve [22].
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activated aptazymes
As before, we assume that the inactive conformer in a two-
state model is completely inactive, and that the active
conformer has the same cleavage rate constant as the ribozyme
sans aptamer. The kinetic model for gene regulation via
ligand-activated self-cleavage is shown in Figure 3C.F o r
simplicity only the 39 UTR is shown. In this model, mRNA is
transcribed from the ‘gene’ (G) with a zero-order rate constant
of vTxn. The nascent transcript (I) can fold into either aptazyme
conformer [cleavage-incompetent conformer (A) or cleavage-
competent conformer (B)] with folding and unfolding rate
constants kFoldA, kFoldB and kUnA, kUnB, respectively. The B (but
not A) conformer can also bind the ligand L to form
aptazyme:ligand complex BL which has the same catalytic
activity as B (kCle). The second-order association rate constant
and first-order dissociation rate constant are denoted as kOn
and kOff, respectively.
Under this model (see Text S2 for derivation), the
relationship between steady-state relative concentration of
intact mRNA (including I, A, B and BL) and the concentr-
ation of total ligand L ([Ltot]) is expressed in the following
equation:
½R Rel~
1
1z
(1zL
 
)b
az(1zL
 )b
:D
ð19Þ
where
a~
kfoldA
kUnAzkDeg
ð20Þ
b~
kfoldB
kUnBzkDegzkClezkDeg:L
  ð21Þ
and
L
 
~
½Ltot kOn
kOffzkDegzkCle
: ð22Þ
This definition of relative concentration L
 
is similar to our
earlier definition of relative ligand concentration, except that in
Figure 3. Models of aptazyme-based riboswitches. (A) Kinetic model for mRNA metabolism in the absence of ribozyme or aptazyme cleavage.
(B) Kinetic model for mRNA metabolism when a constitutively active ribozyme is inserted into the 39 UTR. (C) Kinetic model for mRNA metabolism
when a ligand-activated aptazyme is inserted into the 39 UTR. (D) Kinetic model for mRNA metabolism when a ligand-inhibited aptazyme is inserted
into the 39 UTR.
doi:10.1371/journal.pcbi.1000620.g003
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kOffzkDegzkCle
kOn
which we term the apparent dissociation constant and denote as
Kd
0. Kd
0 is similar in form to Kd (
kOff
kOn
) and will have a similar value
to Kd when the dissociation rate constant of the ligand:aptamer
complex (kOff values typically 10
23 to 10
1 s
21) is much higher than
the cleavage rate constant of the ribozyme (kCle values typically
10
22 to 1 s
21). However, it may also have a larger value than Kd
when kOff is comparable to or lower than kCle. Again, Kd
0 is the
scaling factor for ligand concentration.
Since the degradation rate constant of mRNA in eukaryotic
cells is much slower (by up to 10 orders of magnitude; [23]) than
structural transition, ligand dissociation, and ribozyme cleavage
rates, a and b should have values similar to the equilibrium
constants for the reactions I«A (
kFoldA
kUnA
) and I«B (
kFoldB
kUnB
).
Notably, b can be treated as a constant although it is actually a
function of ligand concentration.
When b is treated as a constant,
b
a
is similar to Kint in Figure 2
and consequently
b
azb
is equivalent to the cleavage tendency v.
Moreover, since the folded state is typically of lower energy (and
thus more occupied) than the intermediate (I) or unfolded state, a
is usually much greater than 1. Given these two conditions, the
equation (19) can be written as:
½R Rel~
1
1z
v 1zL
  
1{v ðÞ zv 1zL
  ðÞ
:D
ð23Þ
It is interesting that equation (23) can be simply obtained by
replacing kCle in (17) with kapp in (4). This suggests that the
equation for the function of aptazymes in vitro (4) can be used for
aptazymes in vivo, with the only significant error coming when kCle
is on the same order as or larger than kOff, which would in turn
lead to a significant difference between Kd
0 and Kd.
Design principles for ligand-activated aptazymes as in
vivo riboswitches
Characteristics of the transfer function. The aptazyme
regulation of steady-state mRNA concentration can be thought of
as ‘cascaded’ hyperbolic control in which the apparent cleavage
activity of the ribozyme (kapp) is hyperbolically controlled by
relative ligand concentration (L
 
) and [R]Rel is in turn
hyperbolically controlled by the cleavage activity of the
ribozyme. Mathematically it can be proven that regulatory
elements that exhibit hyperbolic responsivity also exhibit
hyperbolic responsivity when coupled in series. In general, if:
y~
a1zb1x
c1zx
and
z~
a2zb2y
c2zy
then:
z~
a2c1za1b2 ðÞ z a2zb1b2 ðÞ x
a1zc1c2 ðÞ z b1zc2 ðÞ x
,
which means z is hyperbolically controlled by x.
By applying this conclusion to equation (23) it can be seen that
the [R]Rel-vs-L
 
curve is a decreasing hyperbola (Figure 4A),
whose descriptor can be obtained by rearranging (23) to:
½R Rel~
EC
 
50
L
 zEC
 
50
½R Rel(max){½R Rel(min)

z½R Rel(min) ð24Þ
where [R]Rel(max) is the maximum value of [R]Rel in the absence of
ligand; [R]Rel(min) is the lower limit of [R]Rel and is approached at
infinite ligand concentration; and EC
 
50 is the value of the
dimensionless ligand concentration (obtained by dividing by Kd
0)
corresponding to the midpoint between [R]Rel(min) and [R]Rel(max).
As a result:
½R Rel(max)~
1
1zvD
ð25Þ
½R Rel(min)~
1
1zD
ð26Þ
EC
 
50~
1zvD
v 1zD ðÞ
~
1{v
v 1zD ðÞ
z1 ð27Þ
Limits on the theoretical dynamic range. The aim of the
design process is to optimize both the dynamic range of gene
expression (as shown by the range of [R]Rel) and sensitivity to
effector (as shown by EC
 
50). In order to have a large dynamic
range of activity and modulation at low effector concentrations,
aptamers, ribozymes, and mRNAs must be chosen that have
optimal values of Kd, kCle, and kDeg, respectively. In addition,
aptazyme cleavage tendency can be engineered to improve the
dynamic range of activity and responsivity to effector.
For optimization of the dynamic range of activity, it is useful to
think how closely the performance of the aptazyme can approach
either completely cleaving or completely protecting a mRNA. The
difference between complete cleavage of the mRNA and the
theoretical minimum steady-state mRNA level that can be
obtained in the presence of the aptazyme will be called the ‘Floor
Gap’ (Figure 4A). The difference between complete protection
and the theoretical maximum steady-state mRNA level in the
presence of the aptazyme will be called the ‘Roof Gap’
(Figure 4A). The aptamer, ribozyme, mRNA, and aptazyme
variables must be chosen so to have as narrow a ‘Roof Gap’ and
‘Floor Gap’ as possible, while still maintaining high ligand
sensitivity (low EC
 
50).
Going by equation (26), it is clear that for a ligand-activated
aptazyme the ‘Floor Gap’ is solely dependent on the intrinsic
variable D (
kCle
kDeg
). The ‘Floor Gap’ can only be narrowed by
choosing or engineering faster ribozymes and/or more stable
mRNAs.
In contrast, the ‘Roof Gap’ and EC
 
50 are dependent upon the
cleavage tendency of the aptazyme. They also have additional
limitations. According to (27), EC
 
50 is always greater than 1 since
v is always smaller than 1. Thus EC50 is always greater than Kd
0.
Moreover, by comparing equations (25) and (27) we can
appreciate the relationship between the maximum amount of
intact mRNA at steady-state and EC
 
50. Under the common
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EC
 
50{1~
1
1zD
:1{v
v
&
1
vD
and thus
½R Rel(Max)&1{
1
EC50
  ð28Þ
or
0Roof Gap0&
1
EC50
 
Therefore, ‘Roof Gap’ is inversely proportional to EC
 
50, which is
in turn determined by D and the cleavage tendency.
An additional criterion that can be used to evaluate the system is
the fold-inhibition that occurs over the theoretical dynamic range
of gene expression, denoted as gR, Theoretical:
gR, Theoretical~
½R Rel(max)
½R Rel(min)
The ‘Roof Gap’ can be narrowed by engineering a very small
cleavage tendency, i.e., by heavily disfavoring the cleavage-
competent conformer (albeit at the cost of a rising EC
 
50). Under
these circumstances, the primary determinant of gR, Theoretical will
be the ‘Floor Gap’, or [R]Rel(min). For instance, when D can be
made to be as high as 1000, a riboswitch with a theoretical ,1000-
fold inhibition (assuming no constraints on ligand concentration)
can be engineered by designing the cleavage tendency to be ca.
1
10000
. Given these parameters EC50 would be around 10 times
Figure 4. Performance of aptazymes as riboswitches. (A) Ligand-activated aptazyme; (B) Ligand-inhibited aptazyme. The relative ligand
concentration (ligand concentration divided by the Kd
0 of the aptamer) and the relative gene expression level (steady-state mRNA concentration of
the aptazyme-harboring gene divided by that of the un-engineered gene) are shown on the horizontal and vertical axes, respectively.
doi:10.1371/journal.pcbi.1000620.g004
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D should be at least 10. This condition (high D, low cleavage
tendency) satisfies equation (28), and is equivalent to saying that a
high [R]Rel(max) requires a high EC
 
50. However, (28) also shows
that when EC
 
50 is greater than ,5, further increases of EC
 
50
produce only marginal improvements in [R]Rel(max).
This analysis suggests that the principles that apply in vivo are
drastically different from those that apply to in vitro biosensors,
primarily because the observed signals are different from one
another (in one case, a direct readout of catalysis, in the other, a
readout ‘buffered’ by transcription and degradation). From
equation (9) we can see that in the in vitro case where kapp is
essentially the observed signal a gR, Theoretical of 1000 would
therefore require an EC50 of 1,000 times Kd. In contrast, for the in
vivo case, when observing [R]Rel the same gR, Theoretical can be
obtained with higher ligand sensitivity (i.e., with an EC50 of ca.
only 10 times Kd9, as detailed above).
Limits on the realistic dynamic range. Although the
compromise between ligand sensitivity and the theoretical
dynamic range of activity in vivo is not as severe as was the case
for the ligand-activated aptazyme in vitro,t h e[ R]Rel-vs-L
 
curve (in
contrast to kapp-vs-L
 
curve) is a decreasing hyperbola, and its lower
limit is difficult to reach (see Figure 4A). Therefore when D is
sufficiently large, the realistic dynamic range usually depends
primarily on the maximum L
 
. For the example above where the
theoretical dynamic range of [R]Rel is 1,000-fold, even a 500-fold
reduction of [R]Rel requires the intracellular ligand concentration to
be at least 10,0006Kd
0, e.g. for an aptamer with a Kd of 100nM, the
intracellular ligand concentration must be 1mM! The theoretical
and realistic dynamic range of [R]Rel as functions of cleavage
tendency can be seen in the ‘regulatory landscape’ (Figures 5).I n
this Figure, the relationship between three variables (cleavage
tendency, [R]Rel, and ligand concentration) are plotted in two-
dimensions. In order to achieve the third dimension, ligand
concentration is colored. We also examine the relationships
between these variables at two different values of D, 10 and 100.
In these plots the upper limit of achievable ligand concentration
was arbitrarily chosen to be 100 Kd
0. The theoretical dynamic
range of [R]Rel is encompassed within the colored (including black)
region. The black areas represent those regions that are
inaccessible due to difficult-to-achieve relative ligand concentra-
tions. The EC
 
50 value is shown as a dashed line.
Based on the analyses above and an examination of Figure 5,
we can qualitatively conclude that the primary variables that limit
the performance of a ligand-activated aptazyme as a gene-
regulatory element are D and L
 
max. Therefore, in optimizing
riboswitches based on ligand-activated aptazymes one must: (i)
attempt to achieve the tightest ligand-binding possible; (ii) use or
engineer a faster ribozyme and/or a more stable mRNA; (iii)
appropriately disfavor the cleavage-competent conformation; and
(iv) choosea ligandwith highcell-permeabilityand low cytotoxicity.
More quantitatively, the optimal cleavage tendency v can be
determined when the limiting factors D and L
 
max are both known.
By defining gR, Realistic as the fold-inhibition yielded by the
aptazyme over the realistic dynamic range of [R]Rel (or formally:
gR, Realistic~
½R Rel(max)
½R Rel L
 ~L
 
max
 ), the relationship between gR, Realistic
and v can be analytically obtained:
gR, Realistic~
1z DzL
 
maxzDL
 
max

v
1zL
 
maxv

1zDv ðÞ
ð29Þ
As shown in Figure 6A, for any given D and L
 
max there are
always v ‘sweet spots’ where gR, Realistic is maximized. Around these
‘sweet spots’ gR, Realistic is highly sensitive to v, especially when D
and L
 
max are high. The position of the v ‘sweet spot’ (optimal v)
can be analytically obtained by solving
dgR, Realistic
dv
~0. However,
this analytical result does not elucidate mechanistic understanding
and is thus not shown.
Modeling regulation of gene expression by ligand-
inhibited aptazymes
The model for a ligand-inhibited self-cleaving ribozyme is
diagramed in Figure 3D. The primary difference from the
model for a ligand-activated aptazyme (Figure 3C)i st h a tn o w
only the conformer A, instead of both B and BL, can undergo self-
cleavage. Given the parameters in Figure 3C,t h er e l a t i o n s h i p
between relative steady-state concentration of intact mRNA
([R]Rel) and ligand concentration ([Ltot]) is (see Text S2 for
derivation):
½R Rel~
1
1z
a
1zaz(1zL
 )b
D
ð30Þ
where:
a~
kfoldA
kUnAzkDegzkCle
ð31Þ
b~
kfoldB
kUnBzkDegzkDeg:L
  ð32Þ
L
 
~
½Ltot kOn
kOffzkDeg
ð33Þ
In this case the apparent dissociation constant Kd
0 (
kOffzkDeg
kOn
)i s
closer in value to Kd since kCle does not appear in the definition of
Kd
0. As before, a and b are similar to the equilibrium constants for
the reactions I«A (
kFoldA
kUnA
) and I«B (
kFoldB
kUnB
), respectively, and b
can be treated as a constant. Given that
a
azb
~v, when a is much
greater than 1 then equation (30) can be re-written as:
½R Rel~
1
1z
v
vz 1{v ðÞ 1zL
  ðÞ
:D
: ð34Þ
Since the inhibition of aptazyme cleavage would result in a
increase of gene expression, the [R]Rel-vs-L
 
curve is an increasing
hyperbola, whose descriptor can be obtained by re-writing (34) to:
½R Rel:~
L
 
L
 zEC
 
50
½R Rel(max){½R Rel(min)

z½R Rel(min)
where:
½R Rel(min)~
1
1zvD
ð35Þ
½R Rel(max)~1 ð36Þ
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EC
 
50~
1zvD
1{v
ð37Þ
From these results it can be seen that the ‘Roof Gap’
(Figure 4B) for a ligand-inhibited aptazyme is always 0, since
the mRNA can theoretically be completely protected when the
concentration of the ligand approaches infinite. In contrast,
the width of the ‘Floor Gap’ is dependent on D and the
cleavage tendency v. As before, the theoretical and realistic
dynamic ranges of gene expression are graphically represented
as a regulatory landscape (Figures 5E–5F). Analytically, by
defining:
Figure 5. Regulatory landscapes for aptazyme-based riboswitches. (A) A guide to interpreting the regulatory landscape figures. When the
type of aptazyme (ligand-activated or ligand-inhibited) and the values of D and L
 
max are all known, the regulatory landscape of a given riboswitch
can be determined. The left panel shows an example of a ligand-inhibited aptazyme with D~10 and L
 
max~100. Different cleavage tendencies (v,
horizontal axis) and relative gene expression levels (vertical axis) are related by relative ligand concentrations (indicated by color mapping; the color
scale is shown on the top of the right panel). The dynamic range of activities for a given v can be determined by drawing a vertical line and looking
at the relative gene expression levels at relative ligand concentrations 0 and 100. Such a vertical line is shown for a v of 0.7, and the dynamic range
(the ratio of the values at points C and A) is ca. 6-fold. The relative concentration at point B corresponds to the EC
 
50 of this riboswitch. The dashed
gray line represents the span of relative EC50 (EC
 
50) values. (B to D) The regulatory landscapes of ligand-activated aptazymes with different D values
(=10 and 100) but the same L
 
max value (=100). Note that panel D is an expanded view of panel C where v varies from 0 to 0.1 (instead of 0 to 1). (E
to F) The regulatory landscapes of ligand-inhibited aptazymes with different D values (=10 and 100) but the same L
 
max value (=100).
doi:10.1371/journal.pcbi.1000620.g005
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½R Rel(max)
½R Rel(min)
and
gR, Realistic~
½R Rel L
 
~L
 
max

½R Rel(min)
,
it can be shown that:
gR, Theoretical~1zvD ð38Þ
and
gR, Realistic~
1zDv ðÞ 1zL
 
max{L
 
maxv

1zL
 
maxz D{L
 
max

v
: ð39Þ
Once again, for each given D and L
 
max there is an optimal v to
maximize gR, Realistic (Figure 6B). Interestingly, though, for
ligand-inhibited aptazymes a much wider range of cleavage
tendencies give satisfactory gR, Realistic values (Figures 6B,6D).
Analytical import of the model
A major advance in our modeling compared to previous work
([16]) is that we provide practical guidelines for what experiments
should be carried out to develop a quantitative understanding and
prediction of riboswitch function. Based on our analysis, the
performance of an aptazyme-based riboswitch can be quantita-
tively predicted when four parameters are known: (i) the gene
expression level of an unengineered mRNA; (ii) the ratio of the
ribozyme cleavage rate constant to the mRNA degradation rate
constant (D); (iii) cleavage tendency of the aptazyme (v); and (iv)
the maximum available relative concentration of ligand (L
 
max).
Among these four parameters, the gene expression level of an
unengineered mRNA can be trivially measured. Using equation
(18), D can be obtained by measuring the gene expression level of
an mRNA harboring a ribozyme sans aptamer at its 39 UTR (or
elsewhere). Once D is determined, the cleavage tendency can be
predicted based on RNA folding energetics or by measuring the
gene expression level of an aptazyme-harboring mRNA in the
absence of ligand, according to equations (25) and (35).
The only parameter that cannot be directly measured is L
 
max.
However, L
 
max is ligand-specific, aptamer-specific, and organism-
specific, but not design-specific. Therefore if the gR, Realistic for one
aptazyme is measured, L
 
max can be calculated and used to predict
the performance of other aptazymes which contain the same
aptamer and are used in the same organism. To calculate L
 
max
from gR, Realistic one need only solve equations (29) and (39),
yielding:
L
 
max~
1zDv ðÞ gR, Realistic{1

v 1zD{gR, Realistic 1zDv ðÞ
 ð40Þ
for ligand-activated aptazymes and
L
 
max~
1zDv ðÞ gR, Realistic{1

1{v ðÞ 1zDv{gR, Realistic
 ð41Þ
for ligand-inhibited aptazymes.
With such a theoretical framework we can attempt not only to
promulgate engineering principles, but also to analyze previously
designed aptazyme-based riboswitches. As we discussed above,
Win and Smolke generated a series of theophylline-responsive
Figure 6. Quantitative relationships between gR, Realistic and cleavage tendency v. For ligand-activated aptazymes (A) and ligand-inhibited
aptazymes (B), gR, Realistic is defined as fold-inhibition and fold-activation of gene expression across the realistic dynamic range of gene expression.
The relationship between gR, Realistic and cleavage tendency v is shown for different, maximum possible relative ligand concentrations (L
 
max; shown
in different colors).
doi:10.1371/journal.pcbi.1000620.g006
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onto loop I or loop II of the TRSV ribozyme via various
communication domains [14]. When these different constructs
were placed in the 39 UTR of a reporter gene (GFP) modest ,2-
fold effects on gene regulation were observed. One rationale for
the disappointing results was that introduction of aptamer domains
into loop I and loop II disrupted a known, critical tertiary
interaction [24]. Although the original TRSV ribozyme inserted
into the 39 UTR can inhibit the expression of GFP expression to
2% of the unengineered mRNA level, when loop II was extended
the inhibition was only to ,10%. If the steady-state GFP signal
reflects the steady-state concentration of intact mRNA, the D value
for the engineered aptazymes was thus likely to be ,10.
Therefore, the maximum activation and inhibition could never
exceed 10-fold, as shown by Figures 6A and 6B (top panels).
The constructs were inherently restricted by their very design.
Beyond limitations on catalysis, we also suspect that there were
limitations on either the allosteric binding sites or the available
intracellular ligand concentration. Using the data from Figure
S13 of Win and Smolke [14] and equations (25) and (35), the
cleavage tendencies of each aptazyme were calculated (Table 1).
L
 
max was also calculated from each aptazyme construct using
equations (40) and (41) (Table 1). Although many L
 
max values fall
into a narrow range, they were not consistent. Possible
explanations for this inconsistency include: (i) the existence of
‘non-productive’ aptazyme conformations not considered in the
model (e.g., a non-binding and non-cleaving conformation of the
ligand-inhibited aptazyme); and (ii) the possibility that the basic
functionality of either the aptamer or the ribozyme were
significantly altered in the aptazyme designs.
To further our analysis, we assume that the aptazymes showing
the largest L
 
max (,12) did not operate under the caveats stated
above. If so, the maximum available cellular theophylline
concentration was only about 12 times the Kd
0 of the anti-
theophylline aptamer. The anti-theophylline aptamer has a
reported Kd,1mM [25]. Assuming the aptamer retains its affinity
for theophylline in the cellular environment, the calculated L
 
max
indicates that the intracellular concentration would be on the
order of 12 mM, even though the extracellular concentration of
theophylline was 5mM. This discrepancy is consistent with an
early finding that the intracellular concentration of theophylline in
E.coli is 10
3-fold lower than the concentration in media [26], and
with the previous performance of an engineered antiswitch in yeast
[8].
The comparison between the model and the experimental data
from these studies can be visualized in the regulatory landscapes
shown in Figure 7A and 7B, where the calculated cleavage
tendencies and the relative gene expression values are shown both
in the absence of theophylline (circles) and in the presence of
5 mM theophylline (triangles). For most constructs, there was
quantitative agreement between the model and experimental data
with acceptable variance. It should be noted that if we had used
the original, published estimates for the fold-change due to the
aptazyme there would have been virtually no agreement between
model and experiment.
With aptazymes that had an intrinsically limited D (,10) and a
small upper limit of L
* (,12), it was ultimately to be expected that
the maximum fold-change that might be available through
optimization of the communication module was only ,3.5-fold
(Figures 6A and 6B, upper panels) for both ligand-activated
and ligand-inhibited aptazymes.
In order to actually obtain better aptazyme and riboswitch
functionality both a larger D and a higher upper limit of L
* must
be engineered. Our model predicts that by using a 10-fold more
stable mRNA the maximum fold-change can be increased to ,7-
fold (Figure 6A and 6B, lower panels; keeping the upper limit
of L
* constant). For this more stable mRNA when L
* is also
increased to 50 (by using a tighter binding aptamer:ligand pair
and/or a ligand that is better able to penetrate the cell), ,17-fold
regulation can be achieved (Figure 6A and 6B, lower panels).
In summary, the dynamic range of gene expression in the
current aptazyme-based riboswitch system is severely limited by
the cleavage rate of the ribozyme relative to spontaneous mRNA
degradation rate and the achievable intracellular ligand concen-
tration relative to the in vivo Kd of the aptamer. Reasonable
improvements of these factors should lead to a wider dynamic
range of gene expression.
Challenges and future directions
Although throughout the above analyses we assume that the
cleavage tendency can be freely tuned, this is based on the
assumption that for a given sequence design the aptazyme
conformations and their relative energetics can be reliably
predicted. This assumption is questionable. For example, we have
recently designed a series of biosensors based on the anti-thrombin
aptamer, and demonstrated that biosensor properties did not align
with the stabilities based on secondary structural features alone,
but were fit much better by measured stabilities [27]. Similarly,
attempts to computationally design hammerhead aptazymes based
only on secondary structural hypotheses (the ‘slip structure’ model;
[9]) yielded aptazymes that were much less activated [28].
Such discrepancies are likely to be even greater when
intracellular energetics need to be predicted. For example, for
the aptazymes designed by Win and Smolke [14], the cleavage
tendencies calculated from experimental data (Table 1) largely
disagree with the predicted cleavage tendencies calculated from
the thermodynamics data (taken from Table S1 of [14]), as shown
in Figure 7C. In principle, designed aptazymes should be
characterized in vitro to better understand whether and how they fit
either in silico data or the in vivo data. Similarly, a recent attempt at
model-driven design of allosteric shRNAs also yielded only
qualitative agreement with modeling based on secondary struc-
tures [29].
To better ensure coherence between model and reality, many
assumptions and predictions made in our model of aptazyme-
based biosensors and riboswitches need to be tested experimen-
tally. First of all, it is critical to test to what extent the two-state
structural and energetic model is acceptable. In a recent elegant
study on the kinetics of a previously engineered theophylline-
activated hammerhead ribozyme [9], de Silva and Walter
observed four conformations relevant to activation using single-
molecule fluorescent resonance energy transfer (FRET) [30].
Moreover, upon the addition of theophylline the conformational
change of the aptamer domain was observed to be much faster
than that of the ribozyme core. Based on these results the authors
suggested a model for ligand-induced conformational change in
which the aptamer domain is capable of binding ligand even in the
cleavage-incompetent conformation of the aptazyme. Consequent-
ly, the ligand binding of the aptamer domain primes the
conformational change of the communication domain and the
ribozyme domain (induced fit). Whether this mechanism proves to
be general will strongly impact how the kinetics of effector
modulation are modeled, and may alter the equilibrium
arguments we make herein, depending on how the different
energy states are populated.
In addition, parameters relevant to the in vivo environment need
to be characterized in greater detail in order to understand
aptazyme function. For example, translation efficiency and the
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these factors, although ignored in the current model, would
contribute to the background expression level when a ribozyme or
aptazyme is cleaving at full speed [21]. A more fundamental and
largely unknown issue is how the energetics and kinetics of RNA
folding are influenced by the biochemical properties (ionic
strength, viscosity, the presence of RNA chaperons and helicases)
in cellular environments. While predictive models are incomplete
in the absence of such information, it is nonetheless worthwhile to
formulate them so that the functionality of aptazymes can be more
routinely evaluated as these additional variables are acquired.
Methods
The derivations of the fundamental equations (equations (2), (3),
(19) and (30)) that describe how energetic parameters dictate the
performance of aptazymes in vitro and in vivo are provided in the
Text S1 and S2. All figures were produced with MatLab using
the equations described in the text.
The Supplemental Information and Figure 13 from Win and
Smolke [14] were used to derive data for our analyses. The
‘designed cleavage tendency’ presented in our Figure 7C was
calculated using the equations:
Kint~exp {
DGactive{DGinactive
RT

and
v~
Kint
1zKint
where the values of DGactive and DGinactive were taken from the
Supplemental Information Table 2 of reference [14].
Supporting Information
Text S1 Derivation of equations
Found at: doi:10.1371/journal.pcbi.1000620.s001 (0.03 MB
DOC)
Text S2 Derivation of equations
Found at: doi:10.1371/journal.pcbi.1000620.s002 (0.11 MB
DOC)
Table 1. Analysis of the experimental data in Win and Smolke (2007) [14].
Construct GFP L
 
~0

(a.u.
{) GFP L
 
~L
 
max

(a.u.
{) ½R Rel L
 
~0
 { ½R Rel L
 
~L
 
max
 { gR, Realistic v
? L
 
max
}
L2bulgeOff1 31 14 0.62 0.28 2.2 0.06 4.3
L2bulgeOff2 15 8 0.3 0.16 1.9 0.23 2.6
L2bulgeOff3 10 7 0.2 0.14 1.4 0.40 1.4
L1cm10 27 13 0.54 0.26 2.1 0.09 3.3
L2cm1 36 27 0.72 0.54 1.3 0.04 1.3
L2cm4 39 20 0.78 0.4 2.0 0.03 5.1
L2cm5 42 28 0.84 0.56 1.5 0.02 3.4
L2cm9 16 6 0.32 0.12 2.7 0.21 9.2
*
L2cmd 22 7 0.44 0.14 3.1 0.13 9.9
*
L2bulge1 20 43 0.4 0.86 2.2 0.15 9.7
*
L2bulge2 22 38 0.44 0.76 1.7 0.13 3.5
L2bulge3 25 34 0.5 0.68 1.4 0.10 1.3
L2bulge4 21 41 0.42 0.82 2.0 0.14 6.1
L2bulge5 41 49 0.82 0.98 1.2 0.02 10.0
*
L2bulge8 6 18 0.12 0.36 3.0 0.73 11.7
*
L2bulge9 15 36 0.3 0.72 2.4 0.23 6.5
{This arbitrary unit (a.u.) for GFP expression is defined by Win and Smolke [14]. With this definition, the GFP expression level for unengineered mRNA is 50 a.u.. Source of
data: SI Figure 13 of Win and Smolke [14].
{According to the definition of [R]Rel (18) and the assumption that gene expression level is proportional to steady-state intact mRNA level, ½R Rel L
 
~0

and
½R Rel L
 
~L
 
max

are calculated with the following equations:
½R Rel L
 
~0

~
GFP L
 
~0

50 a:u:
½R Rel L
 
~L
 
max

~
GFP L
 
~L
 
max

50 a:u:
.
?The cleavage tendencies (v) are calculated with equations (25) and (35) for ligand-activated and ligand-inhibited aptazymes, respectively. The value of D used in these
calculations is 10 (see text).
1The maximum available relative ligand concentrations (L
 
max) are calculated with equations (40) and (41) for ligand-activated aptazymes and ligand-inhibited
aptazymes, respectively.
*The five constructs that showed high L
 
max are denoted with
*.
doi:10.1371/journal.pcbi.1000620.t001
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Figure 7. Analysis of an aptazyme-based riboswitch in vivo (Win and Smolke (2007) [14]). The regulatory landscapes for ligand-activated
(A) or ligand-inhibited (B) aptazyme-based riboswitches are shown. In these landscapes the value of D is 10, and the value of L
 
max is 12. The
published relative expression levels of the designed aptazymes in the absence of ligand (pink circles) and at saturating concentrations of ligand (pink
triangles) are plotted versus the calculated cleavage tendency [using equations (25) and (35)]. (C) The discrepancy between designed cleavage
tendencies (see Methods) and observed cleavage tendencies (Table 1).
doi:10.1371/journal.pcbi.1000620.g007
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